LIMERICK, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices for critical care and surgery, will stream the first-ever global broadcast of a live procedure using the Rusch EZ-Blocker Endobronchial Blocker at 4 p.m. CET on September 5th.
“This is a great opportunity for clinicians around the world to see first-hand, via the web, the unique clinical benefits of the EZ-Blocker Endobronchial Blocker”
The internationally broadcast webinar, hosted by Teleflex, will stream live from an operating room at Radbound University Nijmegen Medical Centre, The Netherlands, in collaboration with cardio-thoracic anesthesiologists Dr. Jo Mourisse and Dr. Bas Gerritse.
The EZ-Blocker Endobronchial Blocker was developed to provide an improved alternative to double lumen endobronchial tubes and single balloon bronchial blockers to achieve lung isolation. The EZ-Blocker Endobronchial Blocker's unique Y-shaped distal end enables intuitive placement of the balloons in the right or left bronchus when performing thoracic surgical procedures, while also enabling secure placement at the carina. This placement minimizes the need to manipulate the catheter after placement, reducing the potential of cuffs becoming dislodged.
This webinar will provide viewers a closer, more practical look at the EZ-Blocker Endobronchial Blocker's unique design.
"This is a great opportunity for clinicians around the world to see first-hand, via the web, the unique clinical benefits of the EZ-Blocker Endobronchial Blocker," said Jan Bovelander, Vice President, Teleflex Marketing & Business Development, International. "The innovative design provides a practical solution for lung isolation, and we're pleased to demonstrate this product in use."
The webinar portal allows clinicians to ask questions during the placement, which will be answered by one of the anesthesiologists involved in the procedure.
Registration for the webinar is free. Visit www.EZ-Blocker.com to register and to learn more about this exciting new solution for lung isolation procedures.
About Teleflex Incorporated
Teleflex is a leading global provider of specialty medical devices for a range of procedures in critical care and surgery. Our mission is to provide solutions that enable healthcare providers to improve outcomes and enhance patient and provider safety. Headquartered in Limerick, PA, Teleflex employs approximately 11,500 people worldwide and serves healthcare providers in more than 140 countries. Additional information about Teleflex can be obtained from the company's website at teleflex.com.
Any statements contained in this press release that do not describe historical facts may constitute forward-looking statements. Any forward-looking statements contained herein are based on our management's current beliefs and expectations, but are subject to a number of risks, uncertainties and changes in circumstances, which may cause actual results or company actions to differ materially from what is expressed or implied by these statements. These risks and uncertainties are identified and described in more detail in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, Rusch, and EZ-Blocker are trademarks or registered trademarks of Teleflex Incorporated or its affiliates.
© 2013 Teleflex Incorporated. All rights reserved.